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ies in the tropics are necessary to deﬁne the impact and
seasonality of inﬂuenza in these regions. These data could
help identify the optimal timing of vaccination programs and
other measures for the prevention and control of seasonal
and pandemic inﬂuenza in the tropics, including protection
for travelers and control of emerging strains.
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Novel inﬂuenza A H1N1 (NIA) infection in Argentinean
Children — Experience at Hospital de Nin˜os ‘‘Ricardo
Gutiérrez’’
E.L. Lopez ∗, A. Fallo, M.M. Contrini, A. Mistchenko, C.
Molise, S. Neyro, N. Gonzalez, D. Lazzarini, G. Manonelles,
J. Grichener, M. Dastugue, A. Teper, N. Study Group
Hospital de Nin˜os ‘‘Ricardo Gutiérrez’’, Buenos Aires,
Argentina
Background: NIA pandemia (P) began in Argentina dur-
ing respiratory virus season. Hospital Gutiérrez (HG) set
up special outﬁtted examination room trailler; 5000 sus-
pected cases were attended in 2 mo. Health care for P
included 2 different stages: May24-June12, 695 outpatients
mainly school-age were attended [Containment Phase(CP)].
After 17 ds with a widespread disease: June12-July11, 110
children were admitted to HG due to respiratory failure [Mit-
igation Phase(MP)]
Objective: to characterize clinical, lab and treatment of
conﬁrmed NIA patients (pts)
Methods: IFA was used to rule out other RV; conﬁrmation
by RT-PCR
Results: CP: 220/695(61.3%) cases were conﬁrmed;
191students, 15 close contacts (CC), 8 international trav-
elers, 3 teachers; 2 health-workers. The 191 conﬁrmed
student cases are reported: mean age: 9± 3(4-17) yr; 16(8%)
had comorbidity(C). Most frequent symptoms: fever(F)
178(93%) and cough(Co)160(64%). Oseltamivir(Os) was pre-
scribed to 150(78.5%); none of them was hospitalized.
Duration of F and Co was lower in treated than untreated 2,1
vs 3.6 ds, and 4.2 vs 7 ds respectively(p < 0.001). Secondary
cases occurred in 41/297(15%) of CC, 12/31 in CC without
Os prophylaxis (OsP) and 29/266 in CC with OsP(p = 0.0002).
Mild adverse events(AE) by Os were reported in 12% of
treated pts and in 6.3% of CC
MP: 110 NIA cases represented 6.9% of admis-
sions during this period (double of usual seasonal ﬂu
cases/yr). Mean age 43.4(±54.4) mo; 61(55.5%) were
younger than 24 mo. Main symptoms on admission: F
106(97.4%) and bronchiolitis 70(63.6%). C was present in
84/110(76.4%), it was more frequent in children > 24 mo:
38/61(62.3%) than younger 46/49(93.9%)(p < 0.0003). Fif-
teen(13,6%) required ICU. Complications: 69/110(62.7%)
pts; pneumonia 52/110(47.3%); pneumonitis 31/110(28.2%)
[16/52(30.8%) had both X-Ray patterns]; encephalitis 1/110
(0.9%). Os treatment: 108(98.2%); AE 1/108(0.9%): unspe-
ciﬁc exanthema. Mortality 6/110(5.5%); all of them had C;
median age:87mo
Conclusion: NIA was mild in school-age pts
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Admissions by NIA were twice higher than seasonal ﬂu
nnually
Os was well tolerated by children
Os statistically reduced duration of F and Co
Os was effective to prevent secondary cases in CC
Mortality was low in hospitalized children, associated to
omorbidity
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ssessing the risk of Inﬂuenza virus strains isolated from
irds and mammals to humans
. Vdovichenko1,∗, A. Sergeev1, O.K. Demina1, A.
abanov1, A.S. Kudriavcev2, A.V. Pal’cev2, U.E. Narov2,
.N. Shishkina1, I.G. Drozdov1
FRSI State research center of virology and biotechnology
‘Vector’’, Novosibirsk, Russian Federation
Novosibirsk Regional Oncological Clinic, Novosibirsk, Rus-
ian Federation
Background: Inﬂuenza A virus is the subject of research
f many scientists in the world. So now the attention of sci-
ntists focused on the problem of inﬂuenza, ﬁrst because
f the increased outbreaks of avian inﬂuenza in the world
nd the incidence of transmission of the disease to people
ho were in contact with sick birds. Secondly the threat
oday is the inﬂuenza virus of H1N1 subtype, which caused
any diseases among people around the world. In this con-
ection assessment of risk to human inﬂuenza virus strains
f various origins is essential for timely implementation of
ffective anti-epidemic measures in order to prevent the
evelopment of an epidemic or pandemic inﬂuenza. We have
valuated parameters of infectivity of inﬂuenza virus strains
H5N1, H1N1 and H3N2 subtypes) for primary cell culture
btained from human lung tissues.
Methods: Three inﬂuenza A/Chicken/Suzdalka/2/05
H5N1), A/Novosibirsk/1/09 (H1N1) and A/Aichi/2/68
H3N2) virus strains from the collection of research insti-
ute of FRSI SRC VB ‘‘Vector’’ and primary cell cultures
btained from pieces of human lung tissue kindly provided by
olleagues from the Regional Oncology Center of the Novosi-
irsk, Russia have been used.
Results: A comparison of the values 50% cell infect-
ng dose (CID50) of strains found that the susceptibility
f human lung cells to inﬂuenza A/Chicken/Suzdalka/2/05
irus strain in the 10 and 100 times more than values both
/Novosibirsk/1/09 and A/Aichi/2/68 virus strains respec-
ively. However inﬂuenza A/Chicken/Suzdalka/2/05 strain
ad a 10 times lower progeny yield during 20 hours of repli-
ation in human lung cells compared with other strains.
Conclusion: Thus, our studies revealed inﬂuenza
/Chicken/Suzdalka/2/05 virus strain is able to
ore easily infect cells of the respiratory tract of
an, but has a lower replicate activity than both
/Novosibirsk/1/09 and A/Aichi/2/68 virus strains.
nﬂuenza A/Chicken/Suzdalka/2/05 virus strain was iso-
ated during an outbreak of avian ﬂu among wild birds and
oultry in the Novosibirsk region. During this period of the
utbreak have not been established cases of avian inﬂuenza
ransmission from birds to local residents. Perhaps this is due
